Headlines

Celsius Holdings And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Celsius Holdings (CELH), UNIVERSAL INSURANCE HOLDINGS (UVE), Simulations Plus (SLP) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Celsius Holdings (CELH)

42.4% sales growth and 23.23% return on equity

Celsius Holdings, Inc. develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products. It distributes its products through direct-to-store delivery, distributors, supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, gyms, the military, and e-commerce websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is headquartered in Boca Raton, Florida.

Earnings Per Share

As for profitability, Celsius Holdings has a trailing twelve months EPS of $0.77.

PE Ratio

Celsius Holdings has a trailing twelve months price to earnings ratio of 103.53. Meaning, the purchaser of the share is investing $103.53 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.23%.

Sales Growth

Celsius Holdings’s sales growth is 79.2% for the current quarter and 42.4% for the next.

Volume

Today’s last reported volume for Celsius Holdings is 3219650 which is 33.97% below its average volume of 4876660.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 46.2% and 58.8%, respectively.

Previous days news about Celsius Holdings(CELH)

  • According to Zacks on Tuesday, 16 April, "Here, we have highlighted three better-ranked stocks, namely, Sprouts Farmers Market, Inc. (SFM Quick QuoteSFM – Free Report) , Performance Food Group Company (PFGC Quick QuotePFGC – Free Report) and Celsius Holdings (CELH Quick QuoteCELH – Free Report) ."
  • Celsius holdings inc. (celh) declines more than market: some information for investors. According to Zacks on Thursday, 18 April, "It’s also important for investors to be aware of any recent modifications to analyst estimates for Celsius Holdings Inc. These revisions typically reflect the latest short-term business trends, which can change frequently. ", "Investors will be eagerly watching for the performance of Celsius Holdings Inc. in its upcoming earnings disclosure. "

2. UNIVERSAL INSURANCE HOLDINGS (UVE)

11.2% sales growth and 21.24% return on equity

Universal Insurance Holdings, Inc., together with its subsidiaries, operates as an integrated insurance holding company in the United States. It develops, markets, and underwrites insurance products for personal residential insurance, such as homeowners, renters/tenants, condo unit owners, and dwelling/fire; and offers allied lines, coverage for other structures, and personal property, liability, and personal articles coverages. The company also advises on actuarial issues, oversees distribution, administers claims payments, performs policy administration and underwriting, and assists with reinsurance negotiations; places and manages reinsurance programs for the insurance entities; and operates Clovered.com, a digital agency for carrier partners and utilization of digital applications for adjusting claims. It offers its products through a network of independent agents, as well as direct-to-consumer online solutions, including digital insurance agency. The company was formerly known as Universal Heights, Inc. and changed its name to Universal Insurance Holdings, Inc. in January 2001. Universal Insurance Holdings, Inc. was incorporated in 1990 and is headquartered in Fort Lauderdale, Florida.

Earnings Per Share

As for profitability, UNIVERSAL INSURANCE HOLDINGS has a trailing twelve months EPS of $2.22.

PE Ratio

UNIVERSAL INSURANCE HOLDINGS has a trailing twelve months price to earnings ratio of 8.71. Meaning, the purchaser of the share is investing $8.71 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.24%.

Moving Average

UNIVERSAL INSURANCE HOLDINGS’s value is above its 50-day moving average of $18.64 and way above its 200-day moving average of $15.94.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 22.8% and 32.2%, respectively.

Volume

Today’s last reported volume for UNIVERSAL INSURANCE HOLDINGS is 128369 which is 32.48% below its average volume of 190147.

3. Simulations Plus (SLP)

10.7% sales growth and 6.16% return on equity

Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for noncompartmental analysis and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers KIWI, a cloud-based web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; RENAsym for investigating and predicting drug-induced or acute kidney injury; IPFsym, a software tool to treat or cure idiopathic pulmonary fibrosis; and the Monolix Suite, a solution for modeling and simulation. Further, the company provides population modeling and simulation contract research services; and clinical-pharmacology-based consulting services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was founded in 1996 and is headquartered in Lancaster, California.

Earnings Per Share

As for profitability, Simulations Plus has a trailing twelve months EPS of $0.52.

PE Ratio

Simulations Plus has a trailing twelve months price to earnings ratio of 89.46. Meaning, the purchaser of the share is investing $89.46 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.16%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.2%, now sitting on 64.67M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Simulations Plus’s EBITDA is 12.71.

Volume

Today’s last reported volume for Simulations Plus is 90960 which is 14.69% below its average volume of 106625.

4. Chemed Corp (CHE)

7.9% sales growth and 28.59% return on equity

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Earnings Per Share

As for profitability, Chemed Corp has a trailing twelve months EPS of $17.91.

PE Ratio

Chemed Corp has a trailing twelve months price to earnings ratio of 35.39. Meaning, the purchaser of the share is investing $35.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.59%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Chemed Corp’s EBITDA is 66.47.

Moving Average

Chemed Corp’s worth is above its 50-day moving average of $615.61 and way higher than its 200-day moving average of $561.56.

Volume

Today’s last reported volume for Chemed Corp is 43621 which is 46.43% below its average volume of 81440.

5. Builders FirstSource (BLDR)

6.8% sales growth and 31.78% return on equity

Builders FirstSource, Inc., together with its subsidiaries, manufactures and supplies building materials, manufactured components, and construction services to professional homebuilders, sub-contractors, remodelers, and consumers in the United States. It offers lumber and lumber sheet goods comprising dimensional lumber, plywood, and oriented strand board products that are used in on-site house framing; manufactured products, such as wood floor and roof trusses, steel roof trusses, wall panels, stairs, and engineered wood products; and windows, and interior and exterior door units, as well as interior and exterior trims and custom products under the Synboard brand name. The company also offers gypsum, roofing, and insulation products, including wallboards, ceilings, joint treatments, and finishes; and siding, metal, and concrete products, such as vinyl, composite, and wood siding products, as well as exterior trims, other exteriors, metal studs, and cement products. In addition, it provides other building products and services, such as cabinets and hardware, as well as turn-key framing, shell construction, design assistance, and professional installation services. The company was formerly known as BSL Holdings, Inc. and changed its name to Builders FirstSource, Inc. in October 1999. Builders FirstSource, Inc. was founded in 1998 and is based in Dallas, Texas.

Earnings Per Share

As for profitability, Builders FirstSource has a trailing twelve months EPS of $11.93.

PE Ratio

Builders FirstSource has a trailing twelve months price to earnings ratio of 16.81. Meaning, the purchaser of the share is investing $16.81 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.78%.

Sales Growth

Builders FirstSource’s sales growth is negative 1.5% for the current quarter and 6.8% for the next.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 22.6% and a negative 5.9%, respectively.

Revenue Growth

Year-on-year quarterly revenue growth declined by 4.7%, now sitting on 17.1B for the twelve trailing months.

6. DXP Enterprises (DXPE)

6.8% sales growth and 18.44% return on equity

DXP Enterprises, Inc., together with its subsidiaries, engages in distributing maintenance, repair, and operating (MRO) products, equipment, and services to the energy and industrial customers primarily in the United States and Canada. It operates through three segments: Service Centers (SC), Supply Chain Services (SCS), and Innovative Pumping Solutions (IPS). The SC segment offers MRO products, equipment, and integrated services, including technical expertise and logistics services. It offers a range of MRO products in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, fastener, industrial supply, safety products, and safety services categories. This segment serves customers in the oil and gas, food and beverage, petrochemical, transportation, other general industrial, mining, construction, chemical, municipal, agriculture, and pulp and paper industries. The SCS segment manages procurement and inventory management solutions; and offers outsourced MRO solutions for sourcing MRO products, including inventory optimization and management, store room management, transaction consolidation and control, vendor oversight and procurement cost optimization, productivity improvement, and customized reporting services. Its programs include SmartAgreement, a procurement solution for various MRO categories; SmartBuy, an on-site or centralized MRO procurement solution; SmartSource, an on-site procurement and storeroom management solution; SmartStore, an e-Catalog solution; SmartVend, an industrial dispensing solution; and SmartServ, an integrated service pump solution. The IPS segment fabricates and assembles custom-made pump packages, remanufactures pumps, and manufactures branded private label pumps. The company was founded in 1908 and is based in Houston, Texas.

Earnings Per Share

As for profitability, DXP Enterprises has a trailing twelve months EPS of $3.89.

PE Ratio

DXP Enterprises has a trailing twelve months price to earnings ratio of 14.52. Meaning, the purchaser of the share is investing $14.52 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.44%.

Volume

Today’s last reported volume for DXP Enterprises is 96509 which is 15.95% above its average volume of 83232.

Sales Growth

DXP Enterprises’s sales growth is negative 2.9% for the current quarter and 6.8% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 0.2%, now sitting on 1.68B for the twelve trailing months.

Leave a Reply

Your email address will not be published. Required fields are marked *